Bluejay Diagnostics, Inc. (BJDX) Balance Sheet

NASDAQ: BJDXAssets, liabilities, debt and equity over 7 years.

BJDX balance sheet, 2025

December 31, 2025 · U.S. dollars

$7.1M assets = $1.1M liabilities + $6.0M equity

What it owns$7.1MCash & ST investments: $5.2M (72.5%)Cash & ST investments$5.2M · 73%Other current: $298,727 (4.2%)PP&E: $1.6M (23.1%)PP&E$1.6M · 23%Other non-current: $7,905 (0.1%)=How it is financed$7.1MCurrent liabilities: $1.1M (15.7%)Current liabilities$1.1M · 16%Other LT liabilities: $24,751 (0.3%)Shareholders’ equity: $6.0M (83.9%)Shareholders’ equity$6.0M · 84%

Both columns are drawn to the same scale: what BJDX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BJDX financial health

Current ratio4.88
Comfortable · current assets cover current liabilities 4.88×
Debt / equity0.02
Low leverage · $0.02 of debt for each $1 of equity
Equity / assets83.9%
Equity-funded · of assets funded by shareholders
Cash / debt4,296.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BJDX balance sheet trends, 2019–2025

Bluejay Diagnostics, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$916,5182019$7.1M2025+40.7%/yr
Total liabilities$3.8M2019$1.1M2025−18.3%/yr
Shareholders’ equity−$2.9M2019$6.0M2025—
Cash & short-term investments$96,0112019$5.2M2025+94.3%/yr
Total debt$1.1M2019$120,2112025−30.5%/yr
Net cash (debt)−$973,2772019$5.0M2025+$6.0M
Working capital−$276,1972019$4.3M2025+$4.6M
Current ratio0.5220194.882025+4.36
Debt / equity0.0420220.022025−0.02

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BJDX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BJDX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BJDX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BJDX balance sheet

Bluejay Diagnostics, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$5.2M$4.3M$2.2M$10.1M$19.0M$912,361$96,011
Cash & equivalents$5.2M$4.3M$2.2M$10.1M$19.0M$912,361$96,011
Receivables$0$14,564$41,269$0$0$7,965$645
Inventory$0$0$0$0$0$84,762$123,508
Other current assets$298,727$582,374$971,075$1.7M$1.6M$53,106$80,177
Total current assets$5.5M$4.9M$3.2M$11.8M$20.7M$1.1M$300,341
Property, plant & equipment (net)$1.6M$1.7M$1.6M$1.7M$332,747$459,138$611,558
Goodwill & intangible assets$0$0$0$4,457$4,619$4,619$4,619
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$7,905$35,257$28,663$30,754$21,019$0$0
Total assets$7.1M$6.7M$4.9M$13.5M$21.0M$1.5M$916,518
Liabilities
Accounts payable$214,255$145,122$491,474$635,818$295,778$374,928$29,125
Short-term debt$100,000$113,260$162,990$168,706—$1.1M$265,000
Deferred revenue—————$258,922$86,005
Total current liabilities$1.1M$810,368$1.8M$1.6M$637,162$1.8M$576,538
Long-term debt$0$0$0$0$0$0$804,288
Lease obligations$120,211$222,249$352,977$508,444$0——
Other long-term liabilities$24,751$117,556$202,308$339,738$0$3.9M$2.5M
Total liabilities$1.1M$927,924$2.0M$2.0M$637,162$5.7M$3.8M
Shareholders' equity
Common stock & paid-in capital$60$55$124$2,022$2,011$315$315
Retained earnings (deficit)−$41.5M−$34.7M−$27.0M−$17.0M−$7.7M−$4.2M−$2.9M
Accumulated other comprehensive income————−$21.0M−$3.9M−$2.5M
Total shareholders' equity$6.0M$5.7M$2.9M$11.5M$20.4M−$4.2M−$2.9M
Key figures
Total debt$120,211$222,249$352,977$492,621—$1.1M$1.1M
Net cash (debt)$5.0M$4.1M$1.9M$9.6M—−$143,550−$973,277
Working capital$4.3M$4.1M$1.4M$10.1M$20.0M−$787,196−$276,197
Tangible book value$6.0M$5.7M$2.9M$11.5M$20.4M−$4.2M−$2.9M
Current ratio4.886.051.827.1932.430.570.52
Quick ratio4.615.331.276.1729.890.500.17
Debt / equity0.020.040.120.04———
Equity / assets83.9%86.1%59.5%85.4%97.0%−277.2%−320.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 6, 2026); data from EODHD.

BJDX financial position

At the end of fiscal 2025 (December 31, 2025), Bluejay Diagnostics had total assets of $7.1 million (up 6.9% from a year earlier), total liabilities of $1.1 million and shareholders' equity of $6.0 million. It held $5.2 million in cash and short-term investments against $0.1 million of debt, a net cash position of $5.0 million. Its current ratio was 4.88. In the latest quarter (ended June 30, 2026) total assets were $11.5 million and equity $9.4 million.

Related: BJDX income statement, BJDX cash flow statement, BJDX key metrics. See the BJDX stock overview for the latest quote and news.

BJDX balance sheet FAQ

What are Bluejay Diagnostics's total assets?

Bluejay Diagnostics reported total assets of $7.1 million at the end of fiscal 2025 (December 31, 2025), compared with $6.7 million a year earlier.

How much debt does Bluejay Diagnostics have?

Bluejay Diagnostics had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.02.

How much cash does Bluejay Diagnostics have?

Bluejay Diagnostics held $5.2 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $5.0 million.

What is Bluejay Diagnostics's book value?

Bluejay Diagnostics's shareholders' equity (book value) was $6.0 million at the end of fiscal 2025.

What is Bluejay Diagnostics's current ratio?

Bluejay Diagnostics had current assets of $5.5 million and current liabilities of $1.1 million, a current ratio of 4.88 (it can cover its short-term obligations).

Medical Devices: balance sheet